Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
ELOX holding history
Eloxx Pharmaceuticals, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELOX overviewAll 13F holders of ELOXFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −1,466−100.0% | Sold outConverted for a 1-for-40 split | Holders |
| Q3 2022 | 58,622 | $10.0K | <0.1% | −53,138−47.5% | Reduced | Holders |
| Q2 2022 | 111,760 | $30.0K | <0.1% | +111,760 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −22,350−100.0% | Sold out | Holders |
| Q4 2021 | 22,350 | $16.0K | <0.1% | −81,938−78.6% | Reduced | Holders |
| Q3 2021 | 104,288 | $170.0K | <0.1% | +2,628+2.6% | Added | Holders |
| Q2 2021 | 101,660 | $203.0K | <0.1% | +101,660 | New | Holders |